Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumoia

Status:
Not yet recruiting

Trial end date:
2024-05-01

Target enrollment:

Participant gender:

This was a randomized, double-blind, placebo-controlled parallel study.

Phase 2

First Affiliated Hospital of Zhejiang University